Clozapine: The Gold Standard for Treatment-Resistant Schizophrenia episode artwork

EPISODE · Feb 22, 2026 · 7 MIN

Clozapine: The Gold Standard for Treatment-Resistant Schizophrenia

from OSCE Talk · host Osce Talk

In this episode, we break down clozapine — the gold standard treatment for treatment-resistant schizophrenia.Clozapine is one of the most effective antipsychotics available, but it requires careful monitoring and patient education due to its unique side-effect profile.We cover:• What defines treatment-resistant schizophrenia• Why clozapine is used• Mechanism of action (high-yield overview)• Smoking interactions and compliance issues• Slow titration and 48-hour restart rule• Agranulocytosis and blood monitoring schedule• Myocarditis risk• Seizure risk• Severe constipation (often underestimated)• Metabolic side effects• Clozapine and suicide risk reduction• How to counsel a patient in an OSCEWe also discuss key red flags — including infection symptoms that require urgent assessment.This episode is ideal for:Medical studentsOSCE preparationPsychiatry placementsFoundation doctorsGP and acute care rotationsClozapine is powerful — but only safe when monitored properly.

Episode metadata supplied by the publisher feed · Published Feb 22, 2026

Embed this episode

NOW PLAYING

Clozapine: The Gold Standard for Treatment-Resistant Schizophrenia

0:00 7:22

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of OSCE Talk?

This episode is 7 minutes long.

When was this OSCE Talk episode published?

This episode was published on February 22, 2026.

Can I download this OSCE Talk episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!